IL27 and B-cell chronic lymphocytic leukemia: The role of IL-27 in CLL has remained largely unexplored, particularly regarding its effects on checkpoint expression—a significant knowledge gap—given IL-27’s dual nature as both pro-inflammatory and immunosuppressive cytokine [11,12,33,34].